Rank | Gene Set | Z-score |
---|---|---|
1 | tolerance induction (GO:0002507) | 4.92028517 |
2 | NIK/NF-kappaB signaling (GO:0038061) | 4.55589779 |
3 | response to muramyl dipeptide (GO:0032495) | 4.33212855 |
4 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.25008373 |
5 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.84312614 |
6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83519689 |
7 | hepatocyte apoptotic process (GO:0097284) | 3.67276554 |
8 | neutrophil activation involved in immune response (GO:0002283) | 3.52177298 |
9 | regulation of germinal center formation (GO:0002634) | 3.50977622 |
10 | negative regulation of interleukin-12 production (GO:0032695) | 3.49049521 |
11 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48723730 |
12 | positive regulation of p38MAPK cascade (GO:1900745) | 3.36372531 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32629990 |
14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32016507 |
15 | regulation of chronic inflammatory response (GO:0002676) | 3.29700661 |
16 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29174824 |
17 | regulation of RIG-I signaling pathway (GO:0039535) | 3.25398744 |
18 | granulocyte activation (GO:0036230) | 3.24101188 |
19 | megakaryocyte development (GO:0035855) | 3.23115119 |
20 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.21619603 |
21 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.19150353 |
22 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.18854990 |
23 | activation of MAPKKK activity (GO:0000185) | 3.18202524 |
24 | neutrophil activation (GO:0042119) | 3.16868150 |
25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16767967 |
26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16767967 |
27 | definitive hemopoiesis (GO:0060216) | 3.13127521 |
28 | negative regulation of interleukin-6 production (GO:0032715) | 3.11411104 |
29 | positive regulation of heat generation (GO:0031652) | 3.11353956 |
30 | negative regulation of innate immune response (GO:0045824) | 3.11173545 |
31 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.10979217 |
32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07712915 |
33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04851630 |
34 | negative regulation of bone resorption (GO:0045779) | 3.04142146 |
35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02461231 |
36 | myeloid dendritic cell activation (GO:0001773) | 3.00493420 |
37 | myeloid dendritic cell differentiation (GO:0043011) | 2.99035453 |
38 | negative regulation of lipid storage (GO:0010888) | 2.98094610 |
39 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.97922861 |
40 | erythrocyte maturation (GO:0043249) | 2.97668513 |
41 | immunoglobulin mediated immune response (GO:0016064) | 2.97419433 |
42 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.95744055 |
43 | leukocyte aggregation (GO:0070486) | 2.93214541 |
44 | regulation of mast cell degranulation (GO:0043304) | 2.92956358 |
45 | defense response to protozoan (GO:0042832) | 2.91108930 |
46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.90126308 |
47 | response to type I interferon (GO:0034340) | 2.89351968 |
48 | T cell migration (GO:0072678) | 2.88888916 |
49 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.88498118 |
50 | positive regulation of mRNA catabolic process (GO:0061014) | 2.87994023 |
51 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.87795925 |
52 | microglial cell activation (GO:0001774) | 2.87470972 |
53 | negative thymic T cell selection (GO:0045060) | 2.87168166 |
54 | regulation of antigen processing and presentation (GO:0002577) | 2.85479631 |
55 | negative regulation of cell killing (GO:0031342) | 2.83777330 |
56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.83777330 |
57 | macrophage activation involved in immune response (GO:0002281) | 2.83672348 |
58 | negative regulation of interleukin-1 production (GO:0032692) | 2.83057755 |
59 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82658855 |
60 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.81568864 |
61 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.81568864 |
62 | cellular extravasation (GO:0045123) | 2.81437406 |
63 | type I interferon signaling pathway (GO:0060337) | 2.81375129 |
64 | cellular response to type I interferon (GO:0071357) | 2.81375129 |
65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80130518 |
66 | regulation of fever generation (GO:0031620) | 2.79387459 |
67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.78508662 |
68 | embryonic hemopoiesis (GO:0035162) | 2.78399599 |
69 | interferon-gamma production (GO:0032609) | 2.77026422 |
70 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.75063076 |
71 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.74871688 |
72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74804719 |
73 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.74320014 |
74 | response to peptidoglycan (GO:0032494) | 2.73469626 |
75 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.72667138 |
76 | sleep (GO:0030431) | 2.72533097 |
77 | RNA destabilization (GO:0050779) | 2.72469733 |
78 | macrophage activation (GO:0042116) | 2.71791425 |
79 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71389276 |
80 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71389276 |
81 | modulation by symbiont of host immune response (GO:0052553) | 2.71389276 |
82 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71389276 |
83 | modulation by symbiont of host defense response (GO:0052031) | 2.71389276 |
84 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71389276 |
85 | regulation of response to interferon-gamma (GO:0060330) | 2.70609611 |
86 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70317426 |
87 | negative T cell selection (GO:0043383) | 2.70211821 |
88 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.70094223 |
89 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.68245049 |
90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68141837 |
91 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.67530171 |
92 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.66186731 |
93 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.66186731 |
94 | T cell differentiation involved in immune response (GO:0002292) | 2.66186731 |
95 | angiogenesis involved in wound healing (GO:0060055) | 2.65939923 |
96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65764262 |
97 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.65560639 |
98 | germinal center formation (GO:0002467) | 2.64532388 |
99 | positive regulation of cholesterol efflux (GO:0010875) | 2.63850179 |
100 | myeloid cell activation involved in immune response (GO:0002275) | 2.63629661 |
101 | negative regulation of protein autophosphorylation (GO:0031953) | 2.63209991 |
102 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.62424567 |
103 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.61789195 |
104 | B cell homeostasis (GO:0001782) | 2.61707227 |
105 | mature B cell differentiation involved in immune response (GO:0002313) | 2.61610622 |
106 | response to progesterone (GO:0032570) | 2.61380896 |
107 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.59995797 |
108 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59256768 |
109 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.59027485 |
110 | positive regulation of interleukin-2 production (GO:0032743) | 2.58524681 |
111 | regulation of mast cell activation (GO:0033003) | 2.57761066 |
112 | detection of other organism (GO:0098543) | 2.56042106 |
113 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.55862859 |
114 | positive regulation of type 2 immune response (GO:0002830) | 2.55749545 |
115 | regulation of leukocyte degranulation (GO:0043300) | 2.55716921 |
116 | regulation of necroptotic process (GO:0060544) | 2.55422929 |
117 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.52551001 |
118 | dendritic cell differentiation (GO:0097028) | 2.52521933 |
119 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.52107367 |
120 | regulation of mRNA catabolic process (GO:0061013) | 2.49471877 |
121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49052974 |
122 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.47963251 |
123 | mitotic cell cycle arrest (GO:0071850) | 2.47930850 |
124 | erythrocyte development (GO:0048821) | 2.47698530 |
125 | regulation of fibroblast apoptotic process (GO:2000269) | 2.47030336 |
126 | T-helper cell differentiation (GO:0042093) | 2.46687567 |
127 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.46687567 |
128 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44962398 |
129 | leukocyte tethering or rolling (GO:0050901) | 2.44625281 |
130 | positive regulation of interleukin-12 production (GO:0032735) | 2.43809408 |
131 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.42285486 |
132 | negative regulation of granulocyte differentiation (GO:0030853) | 2.41979791 |
133 | response to laminar fluid shear stress (GO:0034616) | 2.40709857 |
134 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.40094820 |
135 | dendritic cell chemotaxis (GO:0002407) | 2.39505672 |
136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.39115098 |
137 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.38645129 |
138 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.38645129 |
139 | cellular response to interleukin-15 (GO:0071350) | 2.38389958 |
140 | myeloid leukocyte activation (GO:0002274) | 2.38358662 |
141 | endoderm formation (GO:0001706) | 2.37991252 |
142 | positive thymic T cell selection (GO:0045059) | 2.37981885 |
143 | energy homeostasis (GO:0097009) | 2.37867069 |
144 | response to interferon-beta (GO:0035456) | 2.37625321 |
145 | positive regulation of interferon-beta production (GO:0032728) | 2.37424010 |
146 | T cell activation involved in immune response (GO:0002286) | 2.35221547 |
147 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.34195859 |
148 | regulation of chemokine biosynthetic process (GO:0045073) | 2.32856850 |
149 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.31699925 |
150 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.31695223 |
151 | response to interleukin-15 (GO:0070672) | 2.31478114 |
152 | response to protozoan (GO:0001562) | 2.31007144 |
153 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.30962741 |
154 | myeloid cell development (GO:0061515) | 2.30169105 |
155 | positive regulation of interferon-alpha production (GO:0032727) | 2.30051275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.93749199 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.61974586 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.22626681 |
4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.81377978 |
5 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.74394915 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.61306078 |
7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.21794825 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.19520181 |
9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.83885118 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79985494 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75496498 |
12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69787221 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69759577 |
14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.69016528 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.52945005 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50436538 |
17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48162131 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45621312 |
19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37679632 |
20 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.37576066 |
21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.37203104 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30326463 |
23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28197229 |
24 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.25182413 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.23041719 |
26 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.18874816 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16981805 |
28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13910817 |
29 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.03634360 |
30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99020256 |
31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.98221896 |
32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95228307 |
33 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91990942 |
34 | * MAF_26560356_Chip-Seq_TH1_Human | 1.91757202 |
35 | * MYB_26560356_Chip-Seq_TH2_Human | 1.90394426 |
36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89155411 |
37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84435331 |
38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83372815 |
39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83352673 |
40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75926751 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.75084866 |
42 | MYC_22102868_ChIP-Seq_BL_Human | 1.73537116 |
43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71806913 |
44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71571239 |
45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64011567 |
46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62737496 |
47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60734835 |
48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59684623 |
49 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.56884262 |
50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56474678 |
51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54678544 |
52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49108997 |
53 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47924576 |
54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.47261635 |
55 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45737406 |
56 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45737406 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44272460 |
58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42674807 |
59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40555496 |
60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.40551717 |
61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38509321 |
62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38455464 |
63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37078845 |
64 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32278801 |
65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32118666 |
66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30714971 |
67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29995579 |
68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29956535 |
69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29229037 |
70 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.27582448 |
71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26508316 |
72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26165148 |
73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25675384 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24867107 |
75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23574959 |
76 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22345747 |
77 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20667888 |
78 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.19722269 |
79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19110057 |
80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16598623 |
81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16085923 |
82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15829089 |
83 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14794682 |
84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14673190 |
85 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.14414805 |
86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14167446 |
87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13739623 |
88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12965125 |
89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11730710 |
90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11334586 |
91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09756958 |
92 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08726693 |
93 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07092500 |
94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05035827 |
95 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04673163 |
96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04624806 |
97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03727551 |
98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03204358 |
99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03083147 |
100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02584293 |
101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02088239 |
102 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01985604 |
103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01876934 |
104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01866270 |
105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00935650 |
106 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00849684 |
107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00235659 |
108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99826745 |
109 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99301060 |
110 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98299693 |
111 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98299693 |
112 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98299693 |
113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98127253 |
114 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97461332 |
115 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97198406 |
116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95666746 |
117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95636185 |
118 | * MAF_26560356_Chip-Seq_TH2_Human | 0.93461685 |
119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92786499 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 2.96269183 |
2 | MP0002877_abnormal_melanocyte_morpholog | 2.92772901 |
3 | MP0009278_abnormal_bone_marrow | 2.78888698 |
4 | MP0001835_abnormal_antigen_presentation | 2.71352152 |
5 | MP0002254_reproductive_system_inflammat | 2.65591159 |
6 | MP0001545_abnormal_hematopoietic_system | 2.47696619 |
7 | MP0005397_hematopoietic_system_phenotyp | 2.47696619 |
8 | MP0002009_preneoplasia | 2.42054641 |
9 | MP0000685_abnormal_immune_system | 2.41867787 |
10 | MP0005671_abnormal_response_to | 2.41668312 |
11 | MP0003436_decreased_susceptibility_to | 2.35223580 |
12 | MP0009785_altered_susceptibility_to | 2.17798476 |
13 | MP0005000_abnormal_immune_tolerance | 2.17650648 |
14 | MP0004147_increased_porphyrin_level | 2.15349001 |
15 | MP0003828_pulmonary_edema | 2.12863673 |
16 | MP0009840_abnormal_foam_cell | 2.10163188 |
17 | MP0005387_immune_system_phenotype | 2.08395928 |
18 | MP0001790_abnormal_immune_system | 2.08395928 |
19 | MP0002452_abnormal_antigen_presenting | 2.02766582 |
20 | MP0001800_abnormal_humoral_immune | 2.01781135 |
21 | MP0002148_abnormal_hypersensitivity_rea | 2.00303095 |
22 | MP0005058_abnormal_lysosome_morphology | 1.99107492 |
23 | MP0002166_altered_tumor_susceptibility | 1.98603475 |
24 | MP0006082_CNS_inflammation | 1.97258818 |
25 | MP0004808_abnormal_hematopoietic_stem | 1.96791912 |
26 | MP0005464_abnormal_platelet_physiology | 1.94619737 |
27 | MP0002419_abnormal_innate_immunity | 1.94282240 |
28 | MP0003763_abnormal_thymus_physiology | 1.91801547 |
29 | MP0002723_abnormal_immune_serum | 1.89907944 |
30 | MP0002405_respiratory_system_inflammati | 1.89696230 |
31 | MP0004510_myositis | 1.89063455 |
32 | MP0003300_gastrointestinal_ulcer | 1.85418779 |
33 | MP0002420_abnormal_adaptive_immunity | 1.82089541 |
34 | MP0004947_skin_inflammation | 1.81116178 |
35 | MP0001819_abnormal_immune_cell | 1.81110184 |
36 | MP0002138_abnormal_hepatobiliary_system | 1.78962103 |
37 | MP0008007_abnormal_cellular_replicative | 1.74160159 |
38 | MP0005025_abnormal_response_to | 1.72115586 |
39 | MP0002006_tumorigenesis | 1.71291224 |
40 | MP0002398_abnormal_bone_marrow | 1.68360402 |
41 | MP0003172_abnormal_lysosome_physiology | 1.65970799 |
42 | MP0009333_abnormal_splenocyte_physiolog | 1.65217596 |
43 | MP0002396_abnormal_hematopoietic_system | 1.62136311 |
44 | MP0010155_abnormal_intestine_physiology | 1.61764714 |
45 | MP0005310_abnormal_salivary_gland | 1.60240517 |
46 | MP0001853_heart_inflammation | 1.58423161 |
47 | MP0003303_peritoneal_inflammation | 1.58307304 |
48 | MP0001533_abnormal_skeleton_physiology | 1.56936128 |
49 | * MP0003656_abnormal_erythrocyte_physiolo | 1.54449073 |
50 | MP0001873_stomach_inflammation | 1.51846872 |
51 | MP0000716_abnormal_immune_system | 1.43074694 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.40830518 |
53 | MP0000858_altered_metastatic_potential | 1.35014042 |
54 | * MP0002722_abnormal_immune_system | 1.33624318 |
55 | MP0001845_abnormal_inflammatory_respons | 1.33514492 |
56 | MP0003448_altered_tumor_morphology | 1.32970499 |
57 | * MP0000689_abnormal_spleen_morphology | 1.32674562 |
58 | MP0008004_abnormal_stomach_pH | 1.31179208 |
59 | MP0001879_abnormal_lymphatic_vessel | 1.29372850 |
60 | * MP0002429_abnormal_blood_cell | 1.28582150 |
61 | MP0001851_eye_inflammation | 1.27588789 |
62 | MP0000767_abnormal_smooth_muscle | 1.26622712 |
63 | MP0002933_joint_inflammation | 1.26149409 |
64 | MP0010368_abnormal_lymphatic_system | 1.23526194 |
65 | MP0005023_abnormal_wound_healing | 1.23437384 |
66 | MP0003453_abnormal_keratinocyte_physiol | 1.23226085 |
67 | MP0000465_gastrointestinal_hemorrhage | 1.21107582 |
68 | MP0000703_abnormal_thymus_morphology | 1.20903193 |
69 | MP0002998_abnormal_bone_remodeling | 1.20150509 |
70 | MP0001501_abnormal_sleep_pattern | 1.18736199 |
71 | MP0000604_amyloidosis | 1.18126910 |
72 | MP0003943_abnormal_hepatobiliary_system | 1.17974173 |
73 | MP0000343_altered_response_to | 1.16656993 |
74 | MP0003279_aneurysm | 1.15067325 |
75 | MP0005390_skeleton_phenotype | 1.13710330 |
76 | MP0005166_decreased_susceptibility_to | 1.11092639 |
77 | MP0004883_abnormal_blood_vessel | 1.10600086 |
78 | MP0001542_abnormal_bone_strength | 1.07215595 |
79 | MP0002132_abnormal_respiratory_system | 1.07079283 |
80 | MP0005164_abnormal_response_to | 1.04191635 |
81 | MP0002332_abnormal_exercise_endurance | 1.03937004 |
82 | MP0010352_gastrointestinal_tract_polyps | 1.00314893 |
83 | MP0003566_abnormal_cell_adhesion | 0.99281496 |
84 | MP0008260_abnormal_autophagy | 0.98598182 |
85 | MP0010307_abnormal_tumor_latency | 0.98099483 |
86 | MP0002060_abnormal_skin_morphology | 0.95655083 |
87 | MP0000249_abnormal_blood_vessel | 0.93694533 |
88 | MP0006054_spinal_hemorrhage | 0.93392651 |
89 | MP0000490_abnormal_crypts_of | 0.92731132 |
90 | MP0009764_decreased_sensitivity_to | 0.92363039 |
91 | MP0003075_altered_response_to | 0.90749080 |
92 | MP0008469_abnormal_protein_level | 0.89587136 |
93 | MP0003795_abnormal_bone_structure | 0.89173269 |
94 | MP0005076_abnormal_cell_differentiation | 0.88487467 |
95 | MP0005451_abnormal_body_composition | 0.86917226 |
96 | MP0008995_early_reproductive_senescence | 0.85544940 |
97 | MP0005167_abnormal_blood-brain_barrier | 0.84540844 |
98 | MP0009765_abnormal_xenobiotic_induced | 0.83942335 |
99 | MP0002928_abnormal_bile_duct | 0.82281834 |
100 | MP0001191_abnormal_skin_condition | 0.81572993 |
101 | MP0003091_abnormal_cell_migration | 0.80772299 |
102 | MP0003045_fibrosis | 0.80092248 |
103 | MP0005165_increased_susceptibility_to | 0.77356019 |
104 | MP0003866_abnormal_defecation | 0.76068782 |
105 | MP0001243_abnormal_dermal_layer | 0.73751871 |
106 | MP0009931_abnormal_skin_appearance | 0.71022156 |
107 | MP0008438_abnormal_cutaneous_collagen | 0.70400314 |
108 | MP0003941_abnormal_skin_development | 0.70346287 |
109 | MP0002277_abnormal_respiratory_mucosa | 0.67774352 |
110 | MP0003329_amyloid_beta_deposits | 0.67146836 |
111 | MP0004264_abnormal_extraembryonic_tissu | 0.66784975 |
112 | MP0005075_abnormal_melanosome_morpholog | 0.66675481 |
113 | MP0009763_increased_sensitivity_to | 0.65971551 |
114 | MP0008961_abnormal_basal_metabolism | 0.62453189 |
115 | MP0001216_abnormal_epidermal_layer | 0.55788719 |
116 | MP0001663_abnormal_digestive_system | 0.55218173 |
117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54962854 |
118 | MP0000609_abnormal_liver_physiology | 0.53715052 |
119 | MP0002136_abnormal_kidney_physiology | 0.52522644 |
120 | MP0003690_abnormal_glial_cell | 0.49249712 |
121 | MP0002019_abnormal_tumor_incidence | 0.48214301 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prostate neoplasm (HP:0100787) | 4.75514763 |
2 | Orchitis (HP:0100796) | 4.11422286 |
3 | Myositis (HP:0100614) | 4.10538508 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.09234963 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.09234963 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.09234963 |
7 | Retrobulbar optic neuritis (HP:0100654) | 4.07207172 |
8 | Optic neuritis (HP:0100653) | 4.07207172 |
9 | Eczematoid dermatitis (HP:0000976) | 3.54917651 |
10 | Dysostosis multiplex (HP:0000943) | 3.52217479 |
11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.37547651 |
12 | Recurrent abscess formation (HP:0002722) | 3.35853266 |
13 | Stomach cancer (HP:0012126) | 3.27974018 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21401022 |
15 | Keratoconjunctivitis (HP:0001096) | 3.11304057 |
16 | Keratoconjunctivitis sicca (HP:0001097) | 3.09644302 |
17 | Petechiae (HP:0000967) | 2.95209823 |
18 | Recurrent bacterial skin infections (HP:0005406) | 2.93635405 |
19 | Prolonged bleeding time (HP:0003010) | 2.90602208 |
20 | Pustule (HP:0200039) | 2.86292775 |
21 | Amyloidosis (HP:0011034) | 2.85526337 |
22 | Epistaxis (HP:0000421) | 2.84101901 |
23 | IgG deficiency (HP:0004315) | 2.83209179 |
24 | Increased cerebral lipofuscin (HP:0011813) | 2.77788968 |
25 | Abnormality of the prostate (HP:0008775) | 2.76328154 |
26 | Arterial thrombosis (HP:0004420) | 2.72658289 |
27 | Pulmonary infiltrates (HP:0002113) | 2.72014497 |
28 | Recurrent fungal infections (HP:0002841) | 2.71507141 |
29 | Mediastinal lymphadenopathy (HP:0100721) | 2.71204402 |
30 | Hematochezia (HP:0002573) | 2.71144989 |
31 | Increased serum ferritin (HP:0003281) | 2.68625514 |
32 | Spontaneous hematomas (HP:0007420) | 2.65620834 |
33 | Gangrene (HP:0100758) | 2.64946798 |
34 | Vasculitis (HP:0002633) | 2.64682875 |
35 | Loss of speech (HP:0002371) | 2.60587286 |
36 | Distal lower limb muscle weakness (HP:0009053) | 2.59638009 |
37 | Polycythemia (HP:0001901) | 2.57057195 |
38 | Myocardial infarction (HP:0001658) | 2.52836636 |
39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50328630 |
40 | Obstructive lung disease (HP:0006536) | 2.50328630 |
41 | Poikilocytosis (HP:0004447) | 2.48580455 |
42 | Granulocytopenia (HP:0001913) | 2.45648701 |
43 | Leukocytosis (HP:0001974) | 2.43175499 |
44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42161972 |
45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42161972 |
46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42161972 |
47 | Lip pit (HP:0100267) | 2.41536638 |
48 | Abnormality of T cell physiology (HP:0011840) | 2.41330122 |
49 | Autoimmune hemolytic anemia (HP:0001890) | 2.38891720 |
50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38790409 |
51 | Aortic aneurysm (HP:0004942) | 2.37466824 |
52 | Impaired platelet aggregation (HP:0003540) | 2.36930715 |
53 | Abnormal platelet function (HP:0011869) | 2.36930715 |
54 | Gastrointestinal stroma tumor (HP:0100723) | 2.36493024 |
55 | Amaurosis fugax (HP:0100576) | 2.35931852 |
56 | Abnormality of the fingertips (HP:0001211) | 2.34941128 |
57 | Abnormality of iron homeostasis (HP:0011031) | 2.34284441 |
58 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.33955499 |
59 | Hypergammaglobulinemia (HP:0010702) | 2.32712183 |
60 | Joint swelling (HP:0001386) | 2.31566790 |
61 | Urticaria (HP:0001025) | 2.29961445 |
62 | Increased IgM level (HP:0003496) | 2.29635831 |
63 | Conical tooth (HP:0000698) | 2.29195789 |
64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29159493 |
65 | Thrombocytosis (HP:0001894) | 2.26729521 |
66 | Colitis (HP:0002583) | 2.26427449 |
67 | Severe combined immunodeficiency (HP:0004430) | 2.25536819 |
68 | Autoimmune thrombocytopenia (HP:0001973) | 2.25372903 |
69 | Axonal loss (HP:0003447) | 2.23433218 |
70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22973975 |
71 | Mucopolysacchariduria (HP:0008155) | 2.22973975 |
72 | Parakeratosis (HP:0001036) | 2.22021842 |
73 | Hemoptysis (HP:0002105) | 2.21730305 |
74 | Abnormality of T cell number (HP:0011839) | 2.20591747 |
75 | Inflammation of the large intestine (HP:0002037) | 2.20521897 |
76 | Osteomalacia (HP:0002749) | 2.19526381 |
77 | Aortic valve stenosis (HP:0001650) | 2.18577767 |
78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17294906 |
79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17294906 |
80 | Episodic fever (HP:0001954) | 2.16385913 |
81 | Eosinophilia (HP:0001880) | 2.15376152 |
82 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.14714900 |
83 | Vertebral compression fractures (HP:0002953) | 2.14565809 |
84 | Pulmonary artery stenosis (HP:0004415) | 2.14472409 |
85 | Chest pain (HP:0100749) | 2.14221537 |
86 | Recurrent viral infections (HP:0004429) | 2.10954827 |
87 | Restrictive lung disease (HP:0002091) | 2.10909259 |
88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10732771 |
89 | Cellulitis (HP:0100658) | 2.09782217 |
90 | Anorexia (HP:0002039) | 2.09056712 |
91 | Recurrent skin infections (HP:0001581) | 2.08835191 |
92 | T lymphocytopenia (HP:0005403) | 2.08443339 |
93 | Polyneuropathy (HP:0001271) | 2.08189846 |
94 | Fatigue (HP:0012378) | 2.07069415 |
95 | Spondylolisthesis (HP:0003302) | 2.06245124 |
96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04558153 |
97 | Osteolytic defects of the hand bones (HP:0009699) | 2.04558153 |
98 | Hypertensive crisis (HP:0100735) | 2.03966604 |
99 | Panhypogammaglobulinemia (HP:0003139) | 2.03817187 |
100 | Abnormality of the pleura (HP:0002103) | 2.03327341 |
101 | Systemic lupus erythematosus (HP:0002725) | 2.02817975 |
102 | Syringomyelia (HP:0003396) | 2.02299851 |
103 | Spinal cord lesions (HP:0100561) | 2.02299851 |
104 | Vertigo (HP:0002321) | 2.01328882 |
105 | Keratitis (HP:0000491) | 2.01142089 |
106 | Growth hormone excess (HP:0000845) | 2.00577794 |
107 | Anhidrosis (HP:0000970) | 1.99507405 |
108 | Acute myeloid leukemia (HP:0004808) | 1.98848624 |
109 | Vascular tortuosity (HP:0004948) | 1.98062484 |
110 | Abnormality of the pericardium (HP:0001697) | 1.98002088 |
111 | Gastrointestinal inflammation (HP:0004386) | 1.97785909 |
112 | Gingival bleeding (HP:0000225) | 1.95278310 |
113 | Verrucae (HP:0200043) | 1.94815502 |
114 | Interstitial pulmonary disease (HP:0006530) | 1.92648391 |
115 | IgM deficiency (HP:0002850) | 1.92039297 |
116 | Abnormality of eosinophils (HP:0001879) | 1.91870479 |
117 | Microcytic anemia (HP:0001935) | 1.91755162 |
118 | Abnormality of the nasal mucosa (HP:0000433) | 1.91147729 |
119 | Emphysema (HP:0002097) | 1.86967404 |
120 | Meningitis (HP:0001287) | 1.86750249 |
121 | Recurrent bronchitis (HP:0002837) | 1.86558534 |
122 | Thyroiditis (HP:0100646) | 1.86328955 |
123 | Diaphragmatic weakness (HP:0009113) | 1.85294325 |
124 | Nonimmune hydrops fetalis (HP:0001790) | 1.83170274 |
125 | Alveolar cell carcinoma (HP:0006519) | 1.82299232 |
126 | Bruising susceptibility (HP:0000978) | 1.80716521 |
127 | Abnormality of male internal genitalia (HP:0000022) | 1.79203064 |
128 | Increased IgE level (HP:0003212) | 1.78840886 |
129 | Osteomyelitis (HP:0002754) | 1.77593807 |
130 | Abnormality of T cells (HP:0002843) | 1.77556853 |
131 | Thick nail (HP:0001805) | 1.77132020 |
132 | Broad face (HP:0000283) | 1.76937465 |
133 | Chronic diarrhea (HP:0002028) | 1.76173239 |
134 | Arthralgia (HP:0002829) | 1.74409418 |
135 | Encephalitis (HP:0002383) | 1.73836861 |
136 | Abnormality of macrophages (HP:0004311) | 1.73773734 |
137 | IgA deficiency (HP:0002720) | 1.73326849 |
138 | Glomerulopathy (HP:0100820) | 1.72615708 |
139 | Stomatitis (HP:0010280) | 1.71801101 |
140 | Gastrointestinal infarctions (HP:0005244) | 1.69844013 |
141 | Alopecia of scalp (HP:0002293) | 1.68713296 |
142 | Lymphoma (HP:0002665) | 1.68300555 |
143 | Agammaglobulinemia (HP:0004432) | 1.67787398 |
144 | Vacuolated lymphocytes (HP:0001922) | 1.66728803 |
145 | Arterial tortuosity (HP:0005116) | 1.66035526 |
146 | Periodontitis (HP:0000704) | 1.66035489 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.00532932 |
2 | TGFBR2 | 3.42917987 |
3 | MAPK15 | 3.15855187 |
4 | IKBKB | 2.76220407 |
5 | IKBKE | 2.64642893 |
6 | TIE1 | 2.58817685 |
7 | CHUK | 2.40512319 |
8 | MAPKAPK3 | 2.37520077 |
9 | GRK6 | 2.36544720 |
10 | TBK1 | 2.34082512 |
11 | PRPF4B | 2.33378602 |
12 | RIPK4 | 2.23939122 |
13 | IRAK3 | 2.22327242 |
14 | TXK | 2.18124254 |
15 | EEF2K | 2.14059270 |
16 | JAK3 | 2.09101744 |
17 | TESK2 | 2.05869809 |
18 | PIK3CG | 1.96961976 |
19 | PIM2 | 1.92592026 |
20 | MAP4K1 | 1.90351722 |
21 | IRAK4 | 1.82570216 |
22 | MAP3K3 | 1.81517694 |
23 | NLK | 1.81335201 |
24 | TYK2 | 1.80319536 |
25 | STK10 | 1.75614368 |
26 | FES | 1.72214302 |
27 | TAOK2 | 1.65278294 |
28 | SIK3 | 1.64720428 |
29 | BLK | 1.63664473 |
30 | TRPM7 | 1.62814953 |
31 | MAP2K3 | 1.60547822 |
32 | EPHA3 | 1.58326856 |
33 | PIM1 | 1.57536621 |
34 | MAP3K13 | 1.57421259 |
35 | MAPKAPK5 | 1.57069695 |
36 | KIT | 1.48034992 |
37 | TSSK6 | 1.46689342 |
38 | JAK1 | 1.45907058 |
39 | ZAK | 1.41686487 |
40 | TEC | 1.36121427 |
41 | GRK7 | 1.33111566 |
42 | MAP2K2 | 1.31140336 |
43 | RPS6KB2 | 1.30433750 |
44 | MAP3K11 | 1.30244549 |
45 | ZAP70 | 1.29318308 |
46 | VRK1 | 1.28927243 |
47 | SIK2 | 1.14194301 |
48 | ERN1 | 1.12992309 |
49 | TAOK3 | 1.07996182 |
50 | MST4 | 1.07499806 |
51 | TGFBR1 | 1.07041341 |
52 | MAPKAPK2 | 1.04591774 |
53 | ITK | 1.01193819 |
54 | FGFR4 | 0.99605818 |
55 | EPHB1 | 0.98807507 |
56 | RPS6KA4 | 0.96107834 |
57 | EPHA2 | 0.95572306 |
58 | CLK1 | 0.93010974 |
59 | KDR | 0.92293414 |
60 | CDK12 | 0.91815162 |
61 | MAP3K10 | 0.90116588 |
62 | FLT3 | 0.89431336 |
63 | BTK | 0.88166774 |
64 | HIPK2 | 0.86034447 |
65 | RIPK1 | 0.85891011 |
66 | MAP3K1 | 0.84968029 |
67 | IRAK2 | 0.84953939 |
68 | MAPK7 | 0.82143236 |
69 | MAPK4 | 0.81425680 |
70 | RPS6KA5 | 0.81324824 |
71 | FGFR3 | 0.78996967 |
72 | EIF2AK2 | 0.78837291 |
73 | STK4 | 0.76569405 |
74 | JAK2 | 0.75923194 |
75 | PRKD2 | 0.75563856 |
76 | SIK1 | 0.75024854 |
77 | CDK8 | 0.74920983 |
78 | FGR | 0.73755061 |
79 | DYRK3 | 0.73146017 |
80 | RPS6KA6 | 0.72996695 |
81 | MOS | 0.72762036 |
82 | BMPR2 | 0.71641860 |
83 | LCK | 0.70522521 |
84 | CDK9 | 0.69195438 |
85 | SYK | 0.66810325 |
86 | CDC42BPA | 0.64316461 |
87 | CSK | 0.63807633 |
88 | MAP3K5 | 0.61858633 |
89 | RPS6KC1 | 0.61472614 |
90 | RPS6KL1 | 0.61472614 |
91 | STK24 | 0.61185650 |
92 | CSF1R | 0.59330714 |
93 | ADRBK2 | 0.59239316 |
94 | BRD4 | 0.58454115 |
95 | NEK9 | 0.58204134 |
96 | RPS6KA2 | 0.57161773 |
97 | MARK2 | 0.56323343 |
98 | CDK6 | 0.54300932 |
99 | HCK | 0.53757769 |
100 | TNK2 | 0.50931813 |
101 | BMPR1B | 0.50269623 |
102 | SGK2 | 0.49868152 |
103 | DDR2 | 0.49184073 |
104 | MKNK2 | 0.48238178 |
105 | MAPK12 | 0.47826339 |
106 | PRKAA2 | 0.46246137 |
107 | ABL2 | 0.45844226 |
108 | CDK3 | 0.45805356 |
109 | LYN | 0.45186724 |
110 | ARAF | 0.44208681 |
111 | SGK3 | 0.43524233 |
112 | PRKG2 | 0.43388838 |
113 | MATK | 0.43102559 |
114 | MARK3 | 0.41768509 |
115 | DYRK1B | 0.40944976 |
116 | GSK3A | 0.40564681 |
117 | MAPK3 | 0.40063104 |
118 | PDK1 | 0.39685207 |
119 | IRAK1 | 0.39281027 |
120 | CDK4 | 0.38179566 |
121 | BMX | 0.37737854 |
122 | MAPK11 | 0.37550332 |
123 | MAP3K7 | 0.35000028 |
124 | STK3 | 0.34818261 |
125 | RPS6KA1 | 0.34629676 |
126 | NME2 | 0.34534727 |
127 | PDGFRB | 0.33974055 |
128 | ABL1 | 0.32604185 |
129 | MAP2K1 | 0.32586048 |
130 | INSRR | 0.32225177 |
131 | MAPK1 | 0.29891695 |
132 | TAOK1 | 0.29515138 |
133 | MUSK | 0.29416002 |
134 | MAP3K6 | 0.28023229 |
135 | INSR | 0.27573640 |
136 | PRKCQ | 0.27031285 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.68585721 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64021838 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30039864 |
4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26669683 |
5 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.07837512 |
6 | Measles_Homo sapiens_hsa05162 | 2.04571484 |
7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04368917 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98274055 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94991541 |
10 | Malaria_Homo sapiens_hsa05144 | 1.89612842 |
11 | Legionellosis_Homo sapiens_hsa05134 | 1.86207542 |
12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.84083881 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82382455 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80610691 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77648177 |
16 | Apoptosis_Homo sapiens_hsa04210 | 1.77028423 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74458106 |
18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71926478 |
19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64232199 |
20 | Influenza A_Homo sapiens_hsa05164 | 1.60879933 |
21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57371693 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54266006 |
23 | Allograft rejection_Homo sapiens_hsa05330 | 1.49718570 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.48309783 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45477294 |
26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.43066195 |
27 | Hepatitis B_Homo sapiens_hsa05161 | 1.41949790 |
28 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.38071672 |
29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36911189 |
30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36111891 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.35918074 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34393544 |
33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29847473 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29498862 |
35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22837535 |
36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22255049 |
37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22236503 |
38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.19269505 |
39 | Hepatitis C_Homo sapiens_hsa05160 | 1.16637370 |
40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09203597 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.07423430 |
42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05539047 |
43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04690832 |
44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04165665 |
45 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03865011 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 1.02342042 |
47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01150603 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00905031 |
49 | Prostate cancer_Homo sapiens_hsa05215 | 1.00618561 |
50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96992530 |
51 | Salmonella infection_Homo sapiens_hsa05132 | 0.96618372 |
52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96293847 |
53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92601327 |
54 | Platelet activation_Homo sapiens_hsa04611 | 0.91966559 |
55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90170021 |
56 | Asthma_Homo sapiens_hsa05310 | 0.88383210 |
57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86626906 |
58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86357700 |
59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86291767 |
60 | Bladder cancer_Homo sapiens_hsa05219 | 0.85857971 |
61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85269028 |
62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74959827 |
63 | Phagosome_Homo sapiens_hsa04145 | 0.74217782 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74188420 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.72404373 |
66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68911856 |
67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67898957 |
68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67701188 |
69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66969281 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66605660 |
71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64775015 |
72 | Prion diseases_Homo sapiens_hsa05020 | 0.63975867 |
73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63193760 |
74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61635686 |
75 | Adherens junction_Homo sapiens_hsa04520 | 0.59532931 |
76 | Focal adhesion_Homo sapiens_hsa04510 | 0.59397770 |
77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58786525 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58631860 |
79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58139172 |
80 | Lysosome_Homo sapiens_hsa04142 | 0.57034660 |
81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55913034 |
82 | Insulin resistance_Homo sapiens_hsa04931 | 0.54177698 |
83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53706364 |
84 | Endocytosis_Homo sapiens_hsa04144 | 0.53046310 |
85 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52834106 |
86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52783961 |
87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52472492 |
88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51261477 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49232022 |
90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48991481 |
91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48574865 |
92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47675694 |
93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47409780 |
94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46530156 |
95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46128146 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45732006 |
97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45613150 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45434145 |
99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44257037 |
100 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44209067 |
101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44175957 |
102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43116452 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43114693 |
104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42688573 |
105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42628298 |
106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42626048 |
107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42160248 |
108 | RNA degradation_Homo sapiens_hsa03018 | 0.41429817 |
109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40725420 |
110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40075195 |
111 | ABC transporters_Homo sapiens_hsa02010 | 0.39321488 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38670963 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37579220 |
114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37227192 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35387673 |
116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34309509 |
117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25100044 |
118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23899201 |
119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23383362 |
120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23187746 |